Solesence (SLSN) Liabilities and Shareholders Equity (2016 - 2025)
Solesence's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $50.1 million for Q4 2025.
- For Q4 2025, Liabilities and Shareholders Equity changed 0.11% year-over-year to $50.1 million; the TTM value through Dec 2025 reached $221.0 million, up 24.58%, while the annual FY2025 figure was $50.1 million, 0.11% changed from the prior year.
- Liabilities and Shareholders Equity reached $50.1 million in Q4 2025 per SLSN's latest filing, down from $54.0 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $60.0 million in Q2 2025 to a low of $16.0 million in Q2 2021.
- Average Liabilities and Shareholders Equity over 5 years is $37.2 million, with a median of $34.2 million recorded in 2022.
- Peak YoY movement for Liabilities and Shareholders Equity: surged 115.07% in 2022, then fell 5.0% in 2023.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $28.4 million in 2021, then rose by 18.19% to $33.6 million in 2022, then decreased by 2.02% to $32.9 million in 2023, then skyrocketed by 52.07% to $50.0 million in 2024, then grew by 0.11% to $50.1 million in 2025.
- Per Business Quant, the three most recent readings for SLSN's Liabilities and Shareholders Equity are $50.1 million (Q4 2025), $54.0 million (Q3 2025), and $60.0 million (Q2 2025).